Anthropometry (3)
- BMI - Body Mass Index (phv00405791.v2.p1)
- HEIGHT - Height (phv00405789.v2.p1)
- WEIGHT - Weight (phv00405790.v2.p1)
Biomarkers (35)
- BR - Total Bilirubin (phv00405846.v2.p1)
- BUN - Blood Urea Nitrogen (phv00405847.v2.p1)
- CHOL - Cholesterol (phv00405829.v2.p1)
- DBP1 - 1st Diastolic Blood Pressure (phv00405796.v2.p1)
- DBP2 - 2nd Diastolic Blood Pressure (phv00405798.v1.p1)
- DBP3 - 3rd Diastolic Blood Pressure (phv00405800.v1.p1)
- eGFR - Estimated Glomerular Giltration Rate (phv00405842.v2.p1)
- GLUC - Glucose (phv00405835.v2.p1)
- GOT - Glutamic Oxaloacetic Transaminase (Aspartate aminotransferase) (phv00405845.v2.p1)
- GPT - Glutamic Pyruvic Transaminase (Alanine aminotransferase) (phv00405840.v2.p1)
- Hb - Hemoglobin (phv00405839.v2.p1)
- HbA1c - Glycated hemoglobin (phv00405836.v2.p1)
- HDLC - High-Density Lipoprotein Cholesterol (phv00405831.v2.p1)
- hs_CRP - High sensitive C reaction protein (phv00405849.v2.p1)
- INS - Insulin (phv00405834.v2.p1)
- KK - Serum Potassium (phv00405852.v2.p1)
- LDLC - Low-Density Lipoprotein Cholesterol (phv00405832.v2.p1)
- LDLCALC - Calculated Low-Density Lipoprotein Cholesterol (phv00405833.v2.p1)
- NA - Serum Sodium (phv00426932.v1.p1)
- NEU - Neutrophils (phv00405843.v2.p1)
- OGTT0GLUC - Oral Glucose Tolerance Test 0 min (glucose) (phv00405817.v2.p1)
- OGTT0INS - Oral Glucose Tolerance Test 0 min (insulin) (phv00405820.v2.p1)
- OGTT120GLUC - Oral Glucose Tolerance Test 120 mins (glucose) (phv00405819.v2.p1)
- OGTT120INS - Oral Glucose Tolerance Test 120 mins (insulin) (phv00405822.v2.p1)
- OGTT60GLUC - Oral Glucose Tolerance Test 60 mins (glucose) (phv00405818.v2.p1)
- OGTT60INS - Oral Glucose Tolerance Test 60 mins (insulin) (phv00405821.v2.p1)
- PLCR - Plasma Creatinine (phv00405837.v2.p1)
- PLT - Platelet (phv00405844.v2.p1)
- PR - Pulse Rate (phv00405801.v2.p1)
- SBP1 - 1st Systolic Blood Pressure (phv00405795.v2.p1)
- SBP2 - 2nd Systolic Blood Pressure (phv00405797.v1.p1)
- SBP3 - 3rd Systolic Blood Pressure (phv00405799.v1.p1)
- TG - Triglycerides (phv00405830.v2.p1)
- URIC - Uric Acid (phv00405841.v2.p1)
- WBC - White Blood Cell (phv00405838.v2.p1)
Demographics (3)
- AGE - Age at clinic visit (phv00405787.v1.p1)
- SEX - Sex (phv00405788.v1.p1)
- SEX - Sex (phv00405782.v2.p1)
Disease Events (3)
- DX_DM - Diabetes Mellitus Diagnosis (phv00405806.v2.p1)
- DX_HTN - Hypertension Diagnosis (phv00405804.v2.p1)
- TSH - Thyroid-Stimulating Hormone (phv00405848.v2.p1)
General Health (2)
- HIP - Hip Circumference (phv00405793.v2.p1)
- WAIST - Waist Circumference (phv00405792.v2.p1)
Medications (7)
- HTMED_AB - Anti-HT Meds: AlphaBlockers (phv00405807.v2.p1)
- HTMED_ACEI - Anti-HT Meds: Angiotensin-Converting Enzyme Inhibitors (phv00405809.v2.p1)
- HTMED_ARB - Anti-HT Meds: Angiotensin II Receptor Blockers (phv00405808.v2.p1)
- HTMED_BB - Anti-HT Meds: BetaBlockers (phv00405810.v2.p1)
- HTMED_CCB - Anti-HT Meds: Calcium Channel Blockers (phv00405811.v2.p1)
- HTMED_DIURETIC - Anti-HT Meds: Diuretics (phv00405812.v2.p1)
- HTMED_TOTAL - Number of Anti-Hypertensive Medications (phv00405813.v2.p1)
Study Administration (2)
- DX_CAD - Coronary Artery Disease Diagnosis (phv00405805.v2.p1)
- FASTING - Fasting Status (phv00405816.v2.p1)
Substance Use (1)
- SMOKE - Smoke Cigarettes (phv00405802.v2.p1)
Other (34)
- ALCOHOL - Drink Alcohol (phv00405803.v2.p1)
- ANALYTE_TYPE - Analyte Type (phv00405855.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00405854.v2.p1)
- CA - Serum Calcium (phv00405850.v2.p1)
- CHMED_TOTAL - Number of Cholesterol Medications (phv00405815.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00405773.v2.p1)
- DMMED_TOTAL - Number of Diabetes Medications (phv00405814.v2.p1)
- FAMILY_ID - Family ID (phv00405778.v2.p1)
- FATHER - Father's Subject ID (phv00405780.v2.p1)
- Funding_Source - Project funding source (phv00405859.v2.p1)
- IS_TUMOR - Tumor status (phv00405856.v2.p1)
- MOTHER - Mother's Subject ID (phv00405781.v2.p1)
- SAMPLE_ID - Sample ID (phv00405853.v2.p1)
- SAMPLE_ID - Sample ID (phv00405783.v2.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00405858.v2.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the SUBJECT_SOURCE repository (phv00405775.v2.p1)
- SOURCE_SUBJECT_ID2 - Subject ID used in the SUBJECT_SOURCE2 repository (phv00405777.v2.p1)
- SSPG0 - Steady-state Plasma Glucose 0 min (phv00405823.v2.p1)
- SSPG150 - Steady-state Plasma Glucose 150 mins (phv00405824.v2.p1)
- SSPG160 - Steady-state Plasma Glucose 160 mins (phv00405825.v2.p1)
- SSPG170 - Steady-state Plasma Glucose 170 mins (phv00405826.v2.p1)
- SSPG180 - Steady-state Plasma Glucose 180 mins (phv00405827.v2.p1)
- SSPGMEAN - Steady-state Plasma Glucose Mean (phv00405828.v2.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00405862.v2.p1)
- SUBJECT_ID - Subject Identifier (phv00405785.v1.p1)
- SUBJECT_ID - Subject ID (phv00405772.v2.p1)
- SUBJECT_ID - Unique Subject ID (phv00405779.v2.p1)
- SUBJECT_ID - Subject ID (phv00405784.v2.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00405786.v1.p1)
- SUBJECT_SOURCE - Repository name for dbGaP study also containing this individual (phv00405774.v2.p1)
- SUBJECT_SOURCE2 - Second repository name for dbGaP study also containing this individual (phv00405776.v2.p1)
- TOPMed_Phase - TOPMed Phase (phv00405860.v2.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00405861.v2.p1)
- WHR - Waist Hip Ratio (phv00405794.v2.p1)